Michael Blaiss, MD

The average US family health insurance premium has increased from $6,000 in 2000 to $21,000 in 2022. That’s a 249% increase, or 5.8% per year, more than double inflation. The biggest beneficiaries of this massive increase in costs: health insurance companies. UnitedHealth (largest US insurer) is up 4,120% since 2000 vs. 340% gain for the S&P 500.

FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues | BioSpace biospace.com/article/fda-re… #jobs

U.S. FDA declines to approve Eli Lilly's drug to treat eczema reuters.com/business/healt…

Vaping increases risk of asthma in adolescents even without any tobacco smoking sciencedirect.com/science/articl…

With significant overlap between allergic rhinitis & chronic rhinosinusitis, it's important for primary care clinicians, allergists & otolaryngologists to appreciate various management approaches Excellent review re: surgical management of rhinosinusitis: loom.ly/QX7pOVc

Looking for a current, comprehensive, and fantastic review on allergic fungal sinusitis? We've got you covered in our September issue: loom.ly/qfxizCI

This recent editorial offers important thoughts for all of us to consider regarding the rising costs of prescription medication #MedTwitter loom.ly/bfXZLOY

Nasal spray alternative to EpiPen suffers setback as FDA seeks fresh study reuters.com/business/healt…

Protecting children from poor air quality mottpoll.org/reports/protec… via @csmottpoll

Leading asthma groups tackle definition of clinical remission in treatment of asthma medicalxpress.com/news/2023-09-a… via @medical_xpress

FDA Reviewers Say OTC Decongestant Doesn't Work medpagetoday.com/publichealthpo…

#Immunotherapy improved bronchial epithelial expression of IFN-beta and IFN-lambda while decreasing IL-33, said researchers at Bispebjerg Hospital. Also, Dr. Michael Blaiss of @wheezemd and Dr. Jay Lieberman of @UTHSCMedicine share their Perspectives. bit.ly/3OotyqG

Moving to Threads @wheezemd1. Follow me there.

Alladapt looks to advance food allergy drug to Phase III firstwordpharma.com/story/5750955?… via @fwpharma

Blueprint's Ayvakit gets FDA nod for indolent systemic mastocytosis firstwordpharma.com/story/5743014?… via @fwpharma

Medicare Advantage plans are using algorithms to cut off care for seniors in need. Read previous reporting from @bobjherman and @caseymross trib.al/9tuXcQQ

‘Stunning’ change to United’s colonoscopy coverage roils physicians and patients statnews.com/2023/05/15/uni… via @statnews. Just when you think it can’t get any crazier.

Direct consequences of poorly controlled AR/C include: 💤 Sleep loss leading in daytime fatigue ↘️ Decreased quality of life ➕ More View this pediatric allergic rhinitis activity w/ @wheezemd & Erin Tomlin, MD, FAAP to earn 🆓 #CME: bit.ly/3AjJBhy #MedEd #FOAMed